Levetiracetam Orion

Levetiracetam, the active ingredient in Levetiracetam Orion, is an anticonvulsant presented as an oral tablet for oral use. It is indicated for the treatment of partial, generalized tonic‑clonic and myoclonic seizures in patients with epilepsy, helping to reduce seizure frequency and improve neurological stability.

GNH USA supplies Levetiracetam Orion as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, providing reliable sourcing for regulated markets across Europe and other regions.

Levetiracetam is used in the management of epilepsy, targeting various seizure types. - Partial seizures: reduces seizure frequency in patients with focal onset seizures. - Generalized tonic‑clonic seizures: helps control convulsive episodes and decrease recurrence. - Myoclonic seizures: diminishes rapid muscle jerks associated with myoclonic epilepsy.

Levetiracetam may be associated with a range of adverse reactions, which are categorized by frequency and severity.

Common Side Effects: - Fatigue: feeling of tiredness or lack of energy. - Dizziness: sensation of light‑headedness or unsteadiness. - Headache: mild to moderate cranial pain. - Irritability: increased agitation or mood swings.

Serious or Rare Side Effects: - Severe allergic reactions: rash, swelling, or difficulty breathing. - Mood alterations: depression, anxiety, or suicidal thoughts. - Rare blood disorders: thrombocytopenia or leukopenia.

Before initiating therapy, consider the following precautions. - Renal impairment: adjust dose as recommended by prescriber. - Hepatic dysfunction: monitor liver function tests regularly. - Psychiatric symptoms: observe for mood changes or depression. - Concomitant enzyme‑inducing antiepileptics: may reduce levetiracetam plasma levels. - Store at ambient temperature below 25°C: keep in the original container, protect from moisture.

Levetiracetam can interact with several medicines; awareness of interaction severity guides management.

Major Interactions (Avoid): - Carbamazepine: may decrease levetiracetam concentrations. - Phenytoin: can reduce therapeutic effect of levetiracetam. - Phenobarbital: may lower plasma levels, compromising seizure control.

Moderate Interactions (Monitor Closely): - Alcohol: may enhance central nervous system depression. - Other antiepileptic drugs: dose adjustments may be required. - Renal excretion inhibitors: monitor renal function and consider dose modification.